Universal protocol for the rapid automated detection of carbapenem-resistant Gram-negative bacilli directly from blood cultures by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF/MS)

International Journal of Antimicrobial Agents

Volumn 48, Issue 6, 2016, Pages 655-660

  Oviaño, Marina ^a   Sparbier, Katrin ^b   Barba, Maria José ^a   Kostrzewa, Markus ^b   Bou, Germán ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b BRUKER DALTONIK GMBH   (Germany)

Author keywords

Antimicrobial resistance detection; Blood cultures; Imipenem; MALDI TOF

Indexed keywords

CARBAPENEM; CARBAPENEMASE; IMIPENEM; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLOOD CULTURE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG HYDROLYSIS; ENZYME ACTIVITY; GERMANY; GRAM NEGATIVE INFECTION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY; SOFTWARE; SPAIN; BACTEREMIA; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; HUMAN; HYDROLYSIS; LABORATORY AUTOMATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES; TIME FACTOR;

ANTI-BACTERIAL AGENTS; AUTOMATION, LABORATORY; BACTEREMIA; BETA-LACTAM RESISTANCE; BLOOD CULTURE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; HYDROLYSIS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

EID: 85000916332     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2016.08.024     Document Type: Article

References (35)

1. [1] World Health Organization, Antimicrobial resistance: global report on surveillance 2014. Geneva, Switzerland: WHO http://www.who.int/drugresistance/documents/surveillancereport/en/, 2014 accessed 06.10.16.
2. [2] Vali, L., Dashti, K., Opazo-Capurro, A.F., Dashti, A.A., Al Obaid, K., Evans, B.A., Diversity of multi-drug resistant Acinetobacter baumannii population in a major hospital in Kuwait. Front Microbiol, 23, 2015, 743.
3. [3] Petrosillo, N., Giannella, M., Lewis, R., Viale, P., Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art. Expert Rev Anti Infect Ther 11 (2013), 159–177.
4. [4] Pfeifer, Y., Schlatterer, K., Engelmann, E., Schiller, R.A., Frangenberg, H.R., Stiewe, D., et al. Emergence of OXA-48-type carbapenemase-producing Enterobacteriaceae in German hospitals. Antimicrob Agents Chemother 56 (2012), 2125–2128.
5. [5] Cuzon, G., Ouanich, J., Gondret, R., Naas, T., Nordmann, P., Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 55 (2011), 2420–2423.
6. [6] Pitart, C., Solé, M., Roca, I., Fabrega, A., Vila, J., Marco, F., First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 β-lactamase in Klebsiella pneumoniae in Spain. Antimicrob Agents Chemother 55 (2011), 4398–4401.
7. [7] Potron, A., Poirel, L., Nordmann, P., Derepressed transfer properties leading to the efficient spread of the plasmid encoding carbapenemase OXA-48. Antimicrob Agents Chemother 58 (2014), 467–471.
8. [8] Henig, O., Weber, G., Hoshen, M.B., Paul, M., German, L., Neuberger, A., et al. Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case–control study. Eur J Clin Microbiol Infect Dis 34 (2015), 2063–2068.
9. [9] Kumar, A., Ellis, P., Arabi, Y., Roberts, D., Light, B., Parrillo, J.E., et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136 (2009), 1237–1248.
10. [10] Balkan, I.I., Aygün, G., Aydın, S., Mutcalı, S.I., Kara, Z., Kuşkucu, M., et al. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival. Int J Infect Dis 26 (2014), 51–56.
11. [11] Lee, C.H., Su, T.Y., Ye, J.J., Hsu, P.C., Kuo, A.J., Chia, J.H., et al. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems. J Microbiol Immunol Infect, 2015, 10.1016/j.jmii.2015.06.003 Epub ahead of print.
12. KPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother, 71, 2016, 1744.
13. [13] Bass, S.N., Bauer, S.R., Neuner, E.A., Lam, S.W., Impact of combination antimicrobial therapy on mortality risk for critically ill patients with carbapenem-resistant bacteremia. Antimicrob Agents Chemother 59 (2015), 3748–3753.
14. [14] El-Bouri, K., Johnston, S., Rees, E., Thomas, I., Bome-Mannathoko, N., Jones, C., et al. Comparison of bacterial identification by MALDI-TOF mass spectrometry and conventional diagnostic microbiology methods: agreement, speed and cost implications. Br J Biomed Sci 69 (2012), 47–55.
15. [15] Barba, M.J., Fernández, A., Oviaño, M., Fernández, B., Velasco, D., Bou, G., Evaluation of MALDI-TOF mass spectrometry for identification of anaerobic bacteria. Anaerobe 30 (2014), 126–128.
16. [16] Sparbier, K., Schubert, S., Weller, U., Boogen, C., Kostrzewa, M., Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against β-lactam antibiotics. J Clin Microbiol 50 (2012), 927–937.
17. [17] Burckhardt, I., Zimmermann, S., Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. J Clin Microbiol 49 (2011), 3321–3324.
18. 3, a reliable tool for the direct detection of carbapenemase activity. J Clin Microbiol 53 (2015), 1731–1735.
19. [19] Lasserre, C., De Saint Martin, L., Cuzon, G., Efficient detection of carbapenemase activity in Enterobacteriaceae by matrix-assisted laser desorption ionization-time of flight mass spectrometry in less than 30 minutes. J Clin Microbiol 53 (2015), 2163–2171.
20. [20] Oviaño, M., Barba, M.J., Fernández, B., Ortega, A., Aracil, B., Oteo, J., et al. Rapid detection of OXA-48-producing Enterobacteriaceae by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF). J Clin Microbiol 54 (2015), 754–759.
21. [21] Oviaño, M., Fernández, B., Fernández, A., Barba, M.J., Mouriño, C., Bou, G., Rapid detection of Enterobacteriaceae producing extended spectrum β-lactamases directly from positive blood cultures by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Clin Microbiol Infect 20 (2014), 1146–1157.
22. [22] Jung, J., Popp, C., Sparbier, K., Lange, C., Kostrzewa, M., Schubert, S., Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid detection of β-lactam resistance in Enterobacteriaceae derived from blood cultures. J Clin Microbiol 52 (2014), 924–930.
23. [23] Carvalhaes, C.G., Cayô, R., Visconde, M.F., Barone, T., Frigatto, E.A., Okamoto, D., et al. Detection of carbapenemase activity directly from blood culture vials using MALDI-TOF MS: a quick answer for the right decision. J Antimicrob Chemother 69 (2014), 2132–2136.
24. [24] Pérez-Pérez, F.J., Hanson, N.D., Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40 (2002), 2153–2162.
25. [25] Oteo, J., Saez, D., Bautista, V., Fernández-Romero, S., Hernández-Molina, J.M., Pérez-Vázquez, M., et al. Carbapenemase-producing Enterobacteriaceae in Spain in 2012. Antimicrob Agents Chemother 57 (2013), 6344–6347.
26. [26] Van Looveren, M., Goossens, H., ARPAC Steering Group. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 10 (2004), 684–704.
27. [27] Vila, J., Martí, S., Sánchez-Céspedes, J., Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 59 (2007), 1210–1215.
28. [28] Horneffer, V., Strupat, K., Hillenkamp, F., Localization of noncovalent complexes in MALDI-preparations by CLSM. J Am Soc Mass Spectrom 17 (2006), 1599–1604.
29. [29] Ghebremedhin, B., Halstenbach, A., Smiljanic, M., Kaase, M., Ahmad-Nejad, P., MALDI-TOF MS based carbapenemase detection from culture isolates and from positive blood culture vials. Ann Clin Microbiol Antimicrob, 15, 2016, 5.
30. [30] Monteferrante, C.G., Sultan, S., Ten Kate, M.T., Dekker, L.J., Sparbier, K., Peer, M., et al. Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF. J Antimicrob Chemother 71 (2016), 2856–2867.
31. [31] Hombach, M., von Gunten, B., Castelberg, C., Bloemberg, G.V., Evaluation of the Rapidec Carba NP test for detection of carbapenemases in Enterobacteriaceae. J Clin Microbiol 53 (2015), 3828–3833.
32. [32] Poirel, L., Nordmann, P., Rapidec Carba NP test for rapid detection of carbapenemase producers. J Clin Microbiol 53 (2015), 3003–3008.
33. [33] Kim, J.S., Kang, G.E., Kim, H.S., Kim, H.S., Song, W., Lee, K.M., Evaluation of Verigene blood culture test systems for rapid identification of positive blood cultures. Biomed Res Int, 2016, 2016, 1081536.
34. [34] Tijet, N., Boyd, D., Patel, S., Mulvey, M., Melano, R., Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 57 (2013), 4578–4580.
35. [35] Chong, P., McCorrister, S., Unger, M., Boyd, D., Mulvey, M., Westmacott, G., MALDI-TOF MS detection of carbapenemase activity in clinical isolates of Enterobacteriaceae spp., Pseudomonas aeruginosa, and Acinetobacter baumannii compared against the Carba-NP assay. J Microbiol Methods 111 (2015), 21–23.